239 results
Tricuspid and other interventions for valvular disease
05 Oct 2024 – From AICT-AsiaPCR 2024
Immerse yourself in this captivating session featuring selected clinical case submissions from the AICT-AsiaPCR 2024 conference. Explore a wide range of interventional challenges, including device closure of ruptured sinus of Valsalva aneurysm, balloon valvotomy during pregnancy in a double orifice mitral valve, and unusual femoral complications....
New evidence on TAVI from PCR Companions
17 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 abstract submissions presenting the latest evidence on TAVI. Topics include device success in valve-in-valve TAVI, next-day discharge after TAVI, comparative network meta-analysis of PCI strategies in TAVI patients, factors associated with thrombosis treatment response, and outcomes of a novel balloon-expandable...
TAVI: how to prevent stroke
17 May 2024 – From EuroPCR 2024
This session focuses on strategies for preventing stroke during TAVI procedures. It features case presentations and discussions on the use of cerebral protection devices, including a novel full-body embolic protection device, and the management of complications such as cerebral hyperperfusion syndrome.
Transcatheter solutions for combined valve disease
17 May 2024 – From EuroPCR 2024
This session delves into the transcatheter management of patients with combined valve disease, including cases of concomitant aortic stenosis and mitral regurgitation, failed bioprostheses in both the aortic and mitral valves, and severe aortic regurgitation after previous valve-sparing root replacement. The session features case presentations and...
TAVI: procedural complications - Part 1
17 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Clinical Case submissions, focuses on the management of various procedural complications that can arise during Transcatheter Aortic Valve Implantation (TAVI). Participants will delve into cases involving unexpected outcomes, such as nosecone-related issues, dysphagia and haematemesis, and frozen leaflets in self-expanding...
Coronary issues before, during and after TAVI
16 May 2024 – From EuroPCR 2024
This session presents a series of challenging clinical cases highlighting the complex interplay between coronary artery disease and transcatheter aortic valve implantation (TAVI). Attendees will witness real-world scenarios, including high-risk PCI with concomitant severe aortic stenosis, the management of degenerated aortic bioprostheses with the risk of...
Percutaneous tricuspid treatment in challenging anatomies
16 May 2024 – From EuroPCR 2024
Watch this session on percutaneous tricuspid treatment to explore key cases, including managing tricuspid valve-in-valve implantation in a patient with a giant right atrium, transcatheter edge-to-edge repair post-Mustard procedure, and tricuspid replacement in a challenging extreme anatomy case. You'll also learn about cross-caval treatment for torrential...
TAVI: managing acute procedural complications
16 May 2024 – From EuroPCR 2024
From deep implantation challenges to embolization and iatrogenic dissections, each presentation highlights techniques for addressing critical procedural hurdles. Topics include bailout strategies, managing embolized valves, complex second valve placements, and handling unusual TAVR scenarios, offering insights on navigating complications and ensuring procedural safety.
Valvular and structural interventions
16 May 2024 – From EuroPCR 2024
This session features presentations and discussions on various novel transcatheter technologies for valvular and structural heart interventions. It includes a novel transcatheter tricuspid repair technology, a new endovascular aortic root and total arch stent-graft replacement system, a novel self-expandable transcatheter aortic valve, and a transcatheter mitral...
